On March 26, the Department of Justice (“DOJ”) announced that a California-headquartered healthcare provider, Seoul Medical Group Inc. (“Seoul Medical”), its former president and majority owner, and a Seoul Medical subsidiary were ordered to pay over $62 million for violating the False Claims Act.  According to the DOJ, Seoul Medical allegedly submitted false diagnosis codes to increase payments from the Medicare Advantage Program.  A radiology group that also worked with Seoul Medical agreed to pay $2,350,000 for allegedly conspiring with Seoul Medical.